StreetInsider.com News Articles

Form 8-K Bluejay Diagnostics, For: Jul 21

Wed, 22 Jul 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260722/26802751.html

Form 8-K Bluejay Diagnostics, For: Jul 21

Wed, 22 Jul 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260722/26802751.html

Form 4 Bluejay Diagnostics, For: Jul 21 Filed by: BANK OF AMERICA NA

Wed, 22 Jul 2026 13:38:00 -0400

si-local-file:///var/storage/secattach/20260722/26800808.html

Form 4 Bluejay Diagnostics, For: Jul 21 Filed by: BANK OF AMERICA NA

Wed, 22 Jul 2026 13:38:00 -0400

si-local-file:///var/storage/secattach/20260722/26800808.html

Form 3 Bluejay Diagnostics, For: Jul 20 Filed by: BANK OF AMERICA NA

Wed, 22 Jul 2026 13:30:00 -0400

si-local-file:///var/storage/secattach/20260722/26800770.html

Form 3 Bluejay Diagnostics, For: Jul 20 Filed by: BANK OF AMERICA NA

Wed, 22 Jul 2026 13:30:00 -0400

si-local-file:///var/storage/secattach/20260722/26800770.html

Bluejay Diagnostics completes enrollment in sepsis IL-6 study

Tue, 21 Jul 2026 06:30:42 -0400

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) announced the completion of patient enrollment in its SYMON-II multicenter clinical validation study, reaching its target of 750 patients ahead of schedule, according to a company statement.

The prospective study is designed to evaluate the ability of Bluejay's Symphony IL-6 test to assist clinicians in assessing 28-day all-cause mortality risk in sepsis patients admitted or intended for admission to the intensive care unit. Patients were enrolled across multiple U.S. healthcare institutions.

Preliminary observations from the enrolled population show an approximately 17% 28-day mortality rate. The company said the dataset is intended to support analysis of whether clinical

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Tue, 21 Jul 2026 06:30:00 -0400

ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today announced the successful completion of patient enrollment in its SYMON-II multicenter clinical validation study. The study achieved its targeted enrollment of 750 patients earlier than the Company had originally anticipated, representing an important operational milestone in the development of the Company's Symphony™ rapid diagnostic platform.

SYMON-II is a prospective, multicenter clinical validation study designed to evaluate the ability of Bluejay's Symphony™ IL-6 test to assist clinicians in

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Tue, 21 Jul 2026 06:30:00 -0400

SYMON-II is a prospective, multicenter clinical validation study designed to evaluate the ability of Bluejay's Symphony™ IL-6 test to assist clinicians in

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Tue, 21 Jul 2026 06:30:00 -0400

SYMON-II is a prospective, multicenter clinical validation study designed to evaluate the ability of Bluejay's Symphony™ IL-6 test to assist clinicians in

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Tue, 21 Jul 2026 06:30:00 -0400

SYMON-II is a prospective, multicenter clinical validation study designed to evaluate the ability of Bluejay's Symphony™ IL-6 test to assist clinicians in

Form 4 Bluejay Diagnostics, For: Jul 09 Filed by: HRT FINANCIAL LP

Mon, 13 Jul 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20260713/26762218.html

Form 4 Bluejay Diagnostics, For: Jul 09 Filed by: HRT FINANCIAL LP

Mon, 13 Jul 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20260713/26762218.html

Form 3 Bluejay Diagnostics, For: Jul 09 Filed by: HRT FINANCIAL LP

Mon, 13 Jul 2026 15:03:00 -0400

si-local-file:///var/storage/secattach/20260713/26762178.html

Form 3 Bluejay Diagnostics, For: Jul 09 Filed by: HRT FINANCIAL LP

Mon, 13 Jul 2026 15:03:00 -0400

si-local-file:///var/storage/secattach/20260713/26762178.html

Form 4 Bluejay Diagnostics, For: Jul 08 Filed by: BANK OF AMERICA NA

Fri, 10 Jul 2026 14:37:00 -0400

si-local-file:///var/storage/secattach/20260710/26756890.html

Form 4 Bluejay Diagnostics, For: Jul 08 Filed by: BANK OF AMERICA NA

Fri, 10 Jul 2026 14:37:00 -0400

si-local-file:///var/storage/secattach/20260710/26756890.html

Form 3 Bluejay Diagnostics, For: Jul 07 Filed by: BANK OF AMERICA NA

Fri, 10 Jul 2026 14:28:00 -0400

si-local-file:///var/storage/secattach/20260710/26756859.html

Form 3 Bluejay Diagnostics, For: Jul 07 Filed by: BANK OF AMERICA NA

Fri, 10 Jul 2026 14:28:00 -0400

si-local-file:///var/storage/secattach/20260710/26756859.html

Form EFFECT Bluejay Diagnostics,

Mon, 29 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260629/26701449.html

Form EFFECT Bluejay Diagnostics,

Mon, 29 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260629/26701449.html

Form 424B3 Bluejay Diagnostics,

Fri, 26 Jun 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260626/26699568.html

Form 424B3 Bluejay Diagnostics,

Fri, 26 Jun 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260626/26699568.html

Form S-3 Bluejay Diagnostics,

Wed, 17 Jun 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260617/26660971.html

Form S-3 Bluejay Diagnostics,

Wed, 17 Jun 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260617/26660971.html